BSPKOTCPharmaceutical PreparationsFiscal year ends December 31

Bespoke Extracts, Inc.

Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 12, 2025

$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Community

Notes and questions about Bespoke Extracts from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Bespoke Extracts's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-45 reverse split on Apr 27, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BSPK.

Revenue growth31.8% · median -14.9%

Gross margin47.2% · median 31.4%

Operating margin-45.0% · median -9.0%

Net margin-51.3% · median -64.9%

Advertisement
300 × 250